NexImmune Inc.

0.00
-0.14 (-100.00%)
At close: Mar 03, 2025, 9:30 AM
0.10
100000.00%
Pre-market: Jan 10, 2025, 09:30 AM EST

NexImmune Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Net Income -32.34M -62.51M -50.9M -29.87M -20.55M -12.83M
Depreciation & Amortization 1.02M 994.79K 870.28K 618.99K 436.37K 204.65K
Stock-Based Compensation 3.55M 5.87M 5.98M 1.22M 1.53M 1.21M
Other Working Capital -3.84M 2.54M 1.66M -791.9K -1.08M 112.1K
Other Non-Cash Items 1.21M 520.69K 903.92K 1.27M 2.48K 1.42M
Deferred Income Tax n/a n/a -3.29M 442.13K n/a n/a
Change in Working Capital -4.88M 3.93M 654.57K -89.43K -842.11K 304.05K
Operating Cash Flow -31.43M -51.19M -45.79M -26.4M -19.42M -11.12M
Capital Expenditures -48.72K -1.26M -2.35M -864.66K -1.25M -937.77K
Acquisitions n/a 80.8K -32.06M n/a n/a n/a
Purchase of Investments n/a -21.51M -90.46M n/a -7.07M -17.61M
Sales Maturities Of Investments n/a 73M 39M 1.01M 17.73M 5.95M
Other Investing Acitivies 4.23K 81.93M 32.06M 80.22K 9.9K -40.13K
Investing Cash Flow -44.49K 50.32M -53.81M 221.94K 9.42M -12.64M
Debt Repayment n/a n/a 9.02M 22.44M -18.44K -7.28K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a
Other Financial Acitivies n/a 33.26K 1.15M -357.16K 18.78M 9.19M
Financial Cash Flow n/a 5.18M 124.89M 22.08M 18.76M 9.18M
Net Cash Flow -31.47M 4.3M 25.3M -4.1M 8.77M -14.58M
Free Cash Flow -31.48M -52.45M -48.14M -27.27M -20.66M -12.06M